Ji'nan Bolley Medicine

Jinan Bolley Medicine is a pharmaceutical research and development company based in Jinan, China, specializing in the creation of innovative chemical drugs and high-end generics. The company operates as a comprehensive technical service provider, offering drug synthesis, formulation development, and clinical trial management services to the broader pharmaceutical industry. Its internal R&D pipeline is led by BL-01, a Class 1 innovative drug candidate currently in clinical development for the treatment of acute ischemic stroke. Bolley Medicine focuses primarily on the cardiovascular, cerebrovascular, and oncology therapeutic areas, supported by a modern R&D center and pilot manufacturing facilities. The company is recognized as a high-tech enterprise and a "Gazelle Enterprise" within the Shandong province biotech ecosystem.